White House considering stronger measures to boost COVID-19 vaccinations
Aug 06, 2021
One option being considered is restricting Medicare dollars or other federal funds from nursing homes and other long-term-care facilities that do not require staff to be vaccinated.
Excess mortality seen for seniors with Alzheimer’s disease, dementia in COVID-19
Mar 08, 2022
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
ACP issues final practice points for remdesivir use in COVID-19
Mar 01, 2022
Consider treatment with remdesivir for five days for hospitalized COVID-19 patients who do not require invasive ventilation or ECMO.
U.S. buys 600,000 doses of new COVID-19 treatment still awaiting FDA approval
Feb 11, 2022
The new drug will be distributed to states for free if it receives emergency use authorization from the FDA.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.
Protection against omicron strongest with hybrid immunity
Jun 17, 2022
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers the strongest protection against the omicron infection.
Overall risk of myopericarditis low after COVID-19 vaccine
Apr 12, 2022
The overall incidence of myopericarditis does not differ significantly for those receiving COVID-19 vaccines versus non-COVID-19 vaccines.
Natural immunity protects against SARS-CoV-2 reinfection
Dec 16, 2021
The efficacy of natural infection against reinfection was estimated at 92.3 and 97.6% for beta and alpha variants in cohort in Qatar.
Predictors of smell recovery ID’d in COVID-19 patients
Oct 14, 2021
Age less than 40 years and nasal congestion at the time of COVID-19 infection are positively associated with recovery of smell.